Literature DB >> 18698081

Two novel variants of MOZ-CBP fusion transcripts in spontaneously remitted infant leukemia with t(1;16;8)(p13;p13;p11), a new variant of t(8;16)(p11;p13).

Kiminori Terui, Tomohiko Sato, Shinya Sasaki, Ko Kudo, Takuya Kamio, Etsuro Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18698081     DOI： 10.3324/haematol.13020

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

Review 1.  Crosstalk between epigenetic readers regulates the MOZ/MORF HAT complexes.

Authors:  Brianna J Klein; Marie-Eve Lalonde; Jacques Côté; Xiang-Jiao Yang; Tatiana G Kutateladze
Journal:  Epigenetics       Date:  2013-10-29       Impact factor: 4.528

2.  PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.

Authors:  Yukiko Aikawa; Takuo Katsumoto; Pu Zhang; Haruko Shima; Mika Shino; Kiminori Terui; Etsuro Ito; Hiroaki Ohno; E Richard Stanley; Harinder Singh; Daniel G Tenen; Issay Kitabayashi
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

3.  Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin.

Authors:  Muzaffar Ali; Kezhi Yan; Marie-Eve Lalonde; Cindy Degerny; Scott B Rothbart; Brian D Strahl; Jacques Côté; Xiang-Jiao Yang; Tatiana G Kutateladze
Journal:  J Mol Biol       Date:  2012-10-12       Impact factor: 5.469

4.  Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.

Authors:  Eva A Coenen; C Michel Zwaan; Dirk Reinhardt; Christine J Harrison; Oskar A Haas; Valerie de Haas; Vladimir Mihál; Barbara De Moerloose; Marta Jeison; Jeffrey E Rubnitz; Daisuke Tomizawa; Donna Johnston; Todd A Alonzo; Henrik Hasle; Anne Auvrignon; Michael Dworzak; Andrea Pession; Vincent H J van der Velden; John Swansbury; Kit-fai Wong; Kiminori Terui; Sureyya Savasan; Mark Winstanley; Goda Vaitkeviciene; Martin Zimmermann; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

5.  Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia.

Authors:  Ioannis Panagopoulos; Synne Torkildsen; Ludmila Gorunova; Anne Tierens; Geir E Tjønnfjord; Sverre Heim
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

6.  Identification of the MYST3-CREBBP fusion gene in infants with acute myeloid leukemia and hemophagocytosis.

Authors:  Francianne Gomes Andrade; Elda Pereira Noronha; Rosania Maria Baseggio; Teresa Cristina Cardoso Fonseca; Bruno Marcelo Rocha Freire; Isis M Quezado Magalhaes; Ilana R Zalcberg; Maria S Pombo-de-Oliveira
Journal:  Rev Bras Hematol Hemoter       Date:  2016-07-26

Review 7.  Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention.

Authors:  Thomas Mercher; Juerg Schwaller
Journal:  Front Pediatr       Date:  2019-10-15       Impact factor: 3.418

8.  Congenital Acute Myeloid Leukemia with Unique Translocation t(11;19)(q23;p13.3).

Authors:  Chester K Yarbrough; S Kathleen Bandt; Kyle Hurth; Jennifer A Wambach; Rakesh Rao; Shashikant Kulkarni; Francis V White; John L Frater; Jeffrey R Leonard
Journal:  Cureus       Date:  2015-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.